Market Overview

Alexion Pharma Shares Bounce as Lazard Upgraded to Buy, Sets $102 Price Target

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALXN

DateFirmActionFromTo
May 2015NomuraUpgradesNeutralBuy
May 2015CitigroupMaintainsNeutral
Apr 2015OppenheimerAssumesOutperform

View More Analyst Ratings for ALXN
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (ALXN)

Around the Web, We're Loving...